Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-22-011511
Filing Date
2022-11-17
Accepted
2022-11-17 17:10:46
Documents
1
Period of Report
2022-11-16

Document Format Files

Seq Description Document Type Size
1 form4-11172022_101138.html 4  
1 form4-11172022_101138.xml 4 3235
  Complete submission text file 0001415889-22-011511.txt   4824
Mailing Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345
Business Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345 (858) 794-8889
HALOZYME THERAPEUTICS, INC. (Issuer) CIK: 0001159036 (see all company filings)

EIN.: 880488686 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O VISTERRA, INC. ONE KENDALL SQUARE, #B3301 CAMBRIDGE MA 02139
Business Address
Connaughton Bernadette (Reporting) CIK: 0001662521 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32335 | Film No.: 221399380